The in vitro activity of mecillinam, a 6 /3-amidinopenicillanic acid derivative, was investigated. Mecillinam is not active against most gram-positive coccal or bacilliary forms. Many members of the Enterobacteriaceae are inhibited, with 86% of Escherichia coli, 71% of Klebsiella, 62% of Enterobacter, 75% of Salmonella, 69% of Shigella, and 70% of Citrobacter inhibited by 6 .3 ug/ml. Indolepositive Proteus and Serratia were generally resistant as are Pseudomonas strains. Although mecillinam is hydrolyzed by gram-negative /3-lactamases, the compound inhibits /8-lactamase-producing organisms, particularly E. coli. The conductivity of medium used to determine minimal inhibitory concentration and inoculum size produce markedly different values. In medium of high conductivity, 10 mS, mecillinam is inactive against many strains of bacteria. In all media there is a great difference between the minimal inhibitory and minimal bactericidal levels.
The majority of semisynthetic penicillins which have been of clinical usefulness have been acyl derivatives of 6-aminopenicillanic acid. In 1972 Lund and Tybring (6) described a new group of penicillanic acid derivatives. Antibiotics in this group have a f8-lactam and thiazolidine ring structure but differ in the method by which the side chain is attached at the 6-amino position of the 6-aminopenicillanic acid moiety (Fig. 1) . Studies by several groups (4, 13, 16) have shown that these compounds differ significantly from benzylpenicillin, ampicillin, and cephalosporins in their action against certain gram-negative microorganisms. It has been suggested that the amidino penicillins bind preferentially to different penicillin-binding proteins than do compounds such as ampicillin (7, 15) . Morphological studies also suggest a different mechanism of activity than that seen with semisynthetic penicillins or cephalosporins (4, 9) .
Since the resistance of Escherichia coli to ampicillin has increased in 12.5 ,ug of mecillinam per ml. Mecillinam inhibited a significant number of Klebsiella, 71% by 6.3 ,g/ml, and Enterobacter, 62% by 6.3 ,ug/ ml. Serratia, on the other hand, are resistant with only 12% inhibited by 25 pug/ml. Proteus mirabilis were resistant as were the indolepositive Proteus -P. morganii, P. vulgaris, and P. rettgeri. Salmonella and Shigella species, most of which contain R factors mediating antibiotic resistance to many antibiotics, were inhibited by 0.8 to 6.3 ug/ml. Pseudomonas species, acinetobacters, and bacteroides were uniformly resistant to mecillinam. Haemophilus resistant to ampicillin were not inhibited by mecillinam.
Comparison of the activity of mecillinam and ampicillin determined by broth technique is given in Table 3 . Mecillinam inhibits a significant number of isolates that are resistant to ampicillin. For example, at a level of 3.2 ug/ml, a concentration readily achieved orally with either agent, 61% of E. coli, 50% of Enterobacter, 68% of Klebsiella, 70% of Citrobacter, 66% of Shigella, and 73% of Salmonella were inhibited by mecillinam, but only 12% or less of any of these organisms was inhibited by ampicillin. In contrast, 74% of P. mirabilis was inhibited by ampicillin and only 4% was inhibited by mecillinam. The rare indole-positive Proteus strain which is inhibited by ampicillin also is inhibited by mecillinam.
Effect of growth conditions upon MIC values. Attempts to utilize routine brain heart infusion or Mueller-Hinton medium to determine MIC values gave conflicting results. The ion content or conductivity and the osmolality of a medium have a profound influence upon the mecillinam MIC of many organisms, but not all as Table 4 illustrates. If the activity of mecillinam is determined in nutrient broth, osmolality of 38 mOsM and conductivity of 1.55 mS, almost all the members of the Enterobacteriaceae are susceptible. In contrast, with the NIH medium a doubling of the osmolality and conductivity by use of potassium or sodium salts causes a profound increase in the MIC values for some organisms, but not for others. Use of a Trypticase soy medium, although the specific conductivity and osmolality are comparable to the NIH medium, does not yield as low mecillinam MIC values as are achieved in NIH medium.
Klebsiella, Enterobacter, and Proteus species were most markedly affected by the conductivity of the medium, and most were resistant if the conductivity was 12 mS or greater. In contrast, many E. coli, Shigella, and (Table 6 ). In many instances the differences between the MIC and MBC is 8-to 32-fold. This is in contrast to a twofold increase in the ampicillin MIC of organisms which are susceptible. The MBC was increased with some organisms if the tests were performed in medium of higher osmolality and conductivity ( Table 7) . The MIC was increased with higher inoculum, alkaline medium or medium of conductivity above 9 mS, but the ratio of MIC to MBC was lowered. This is seen with the first seven organisms of Table 7 , whereas the latter four organisms showed an increased difference between the MIC and MBC. If an isolate had as low an MIC value in a medium of low conductivity as it did in a medium of higher conductivity, the MBC was similar to both media in most instances (isolates 1, 8) (Table 7) .
Insensitive variants. In both liquid and solid medium a so-called skip-tube phenomenon was noted with organisms of many species. This occurred rarely in the nutrient broth, which is a medium of low conductivity and osmolality, but was seen frequently if the conductivity of a medium was above 10 mS. We determined the MIC of organisms that showed growth far beyond the clear tubes which would normally be taken as the MIC. Table 8 illustrates that in some instances there was a significant, greater than fourfold increase in the MIC on reincubation. This occurred with E. coli, Enterobacter, and Klebsiella pneumoniae. But other isolates of the same species failed to show any increase in MIC values. Isolation of isolates that had a higher MIC value was unrelated to the level, low or high, of the original MIC. The mecillinam MBC values'of both original isolates and variants were similar. l Although mecillinam is hydrolyzed by f-lactamases of most of the Enterobacteriaceae which we tested, it is hydrolyzed less readily than is ampicillin (Table 9 ). This slower hydrolysis by 8-lactamases may provide time for the compound to reach its receptor sites and initiate damage to the cell. Comparative activity of mecillinam and several other f3-lactam antibiotics is given in Table 10 . Each organism has a (8-lactamase that fits into one of the types classified by Jack and Richmond (5) . Even though mecillinam can be destroyed by all of the ,8-lactamases, the compound shows remarkable activity against these members of the En- terobacteriaceae. Mecillinam is unstable in some of the media tested (Table 11) .
DISCUSSION
Although ampicillin is frequently thought of as an example of a broad-spectrum penicillin, its activity against members of the Enterobacteriaceae is limited. Furthermore, in recent years significant numbers of E. coli (2), Salmonella (12) , and Shigella (11) Kkebsiella pneumonia 0.4 >100 100 0.4 >100 Proteus vulgaris 0.8 >500 100 0.8 >500 a MIC values were determined in NIH medium of 420 mOsM, 12 mS. Samples were taken from tubes which showed slight growth beyond the first clear tube of an assay, and the organisms were used as the overnight inoculum for the retest determination of the MIC value.
b MIC and MBC (,ug/ml). ant to ampicillin, Enterobacter, P. vulgaris, and Pseudomonas, the previously mentioned E. coli, Salmonella, etc., are resistant (2, 11) . Thus there has been room for the development of f-lactam compounds which would enlarge the spectrum of activity afforded by the currently available agents. The discovery of the amidino penicillanic acids (6) has provided a new dimension to penicillanic acid derivatives. Studies on the mechanism of activity of these agents suggest that mecillinam binds to a different binding site than do penicillins and cephalosporins (15) and that compounds of this type may be more involved with alteration of cell shape rather than septum formation or elongation. Previous studies from abroad (16, 17) and the findings contained in this report clearly demonstrate the extensive activity of mecillinam against members of the Enterobacteriaceae. Indeed, mecillinam is active at much lower concentrations than ampicillin is against E. coli, and mecillinam inhibits the majority of ampicinlin-resistant E. coli even though it is hydrolyzed by E. coli f8-lactamases. The activity of mecillinam against Klebsiella, Enterobacter, and Citrobacter is comparable to the latest cephalosporins. Although direct comparison of the activity of cephalothin, cefoxitin, and cefamandole with mecillinam is not given in this paper, many of the isolates used to determine the substrate profiles of these cephalosporins were used in this study (9, 10) and mecillinam (Table 10) Abstr. 144, 1975) suggest that mecillinam acts in vivo in a manner similar to the penicillins. The lack of activity of mecillinam against certain gram-positive species and against anaerobes may be a benefit. The role of these other bacteria in preventing the development of resistant fecal flora has been suggested in recent years (1) . Data which will be presented separately (Neu, submitted for publication) show that mecillinam acts synergistically with most other 1-lactam compounds, either penicillanic acid derivatives or cephalosporins. Thus further investigation of this compound in animal and human infections produced by Enterobacteria is indicated.
